Discovery & Development Analytical Science

The Sweet Revolution in Glycan and Antibody Separations

Monoclonal antibodies and other similar biotherapeutics are playing an ever more important role in the treatment of autoimmune diseases and cancers.

04/09/2015

sponsored by Thermo Fisher Scientific

Monoclonal antibodies and other similar biotherapeutics are playing an ever more important role in the treatment of autoimmune diseases and cancers. It is predicted that within a few years, seven of the top ten pharmaceuticals will be antibodies.

Unfortunately, these proteins are extremely hard to characterize, due to an almost infinite number of variants, exacerbated by post translational modifications such as charge variance and aggregation. The number, type and location of glycans adds a further degree of complexity.

We discuss these difficulties and also the current technologies used to maximize separation capabilities and structural elucidation.

Visit our Webinar Hub

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.